Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results
INTERPACE BIOSCIENCES INC (IDXG)
Last interpace biosciences inc earnings: 11/13 04:40 pm
Check Earnings Report
US:NASDAQ Investor Relations:
interpacediagnostics.com/investors
Company Research
Source: GlobeNewswire
?Q4 and FY Test volume increase 21% and 17% year-over-year ?Q4 and FY Volume, Revenue, and Profitability at all-time record levels PARSIPPANY, NJ, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced preliminary financial and business results for the fiscal year and fourth quarter ended December 31, 2024. Fourth quarter Molecular Volume increased 21% year-over-year compared to Q4 2023, and 17% for the Full Year resulting in double-digit Q4 and YTD revenue growth. “The Company achieved record test volume, test revenue, income, and cash collections in Q4 and full year 2024,” said Chris McCarthy, Chief Financial Officer. “The Company’s strategic focus on operational and efficiency improvements also delivered record gross and net income margins.” McCarthy added. “Q4 continued the Company’s trend of double-digit year-over-year volume and revenue growth fueled by the full suite of Interpace testing services. Phys
Show less
Read more
Impact Snapshot
Event Time:
IDXG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IDXG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IDXG alerts
High impacting INTERPACE BIOSCIENCES INC news events
Weekly update
A roundup of the hottest topics
IDXG
News
- Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital Partners [Yahoo! Finance]Yahoo! Finance
- Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital PartnersGlobeNewswire
- Interpace Biosciences GAAP EPS of $0.04, revenue of $8.76M [Seeking Alpha]Seeking Alpha
- Interpace Biosciences Announces Third Quarter 2025 Financial and Business Results [Yahoo! Finance]Yahoo! Finance
- Interpace Biosciences Announces Third Quarter 2025 Financial and Business ResultsGlobeNewswire
IDXG
Sec Filings
- 12/3/25 - Form 8-K
- 11/12/25 - Form 8-K
- 11/12/25 - Form 10-Q
- IDXG's page on the SEC website